What’s inside
View ResearchExplore the long-term effectiveness of grass, birch, and mugwort pollen allergen immunotherapy (AIT) over 18 years. This national cohort study in Denmark analyzed data from 7,914 patients, revealing that AIT significantly reduced the need for anti-allergic nasal sprays in the first 5 years post-treatment, with the effects persisting variably over longer periods. The findings emphasize AIT's potential to improve allergy management and patient quality of life.
Long-Term Effectiveness of Pollen Immunotherapy
Analyzing the 18-year effectiveness of grass, birch, and mugwort pollen immunotherapy in Denmark.
National Cohort Study on Pollen AIT
Cohort study using Danish register-data to assess pollen allergen immunotherapy (AIT) for allergic rhinitis.
Reduced Nasal Spray Use with Pollen AIT
Study shows lower use of nasal spray in the first 0-5 years after starting pollen AIT compared to non-treated individuals.
Persistent Allergic Rhinitis and AIT Effectiveness
Post-hoc analyses indicate consistent AIT effectiveness among patients with persistent allergic rhinitis.
Methodology of Pollen AIT Study
Detailed methods of a register-based cohort study on the long-term effects of pollen allergen immunotherapy in Denmark.
Comprehensive Data Analysis in Pollen AIT Study
Using detailed individual-level data and propensity score matching to evaluate the effectiveness of pollen AIT over 18 years.
.svg)
.jpg)
.webp)
